Holen Sie sich die Stockscreener-App
59.37
1.07%
-0.66
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CYTK?
Forum
Prognose
Aktiensplit
Cytokinetics Inc Aktie (CYTK) Neueste Nachrichten
Portnoy Law Firm Announces Class Action on Behalf of Cytokinetics, Incorporated Investors - GlobeNewswire
Cytokinetics Inc (CYTK) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Key metrics from Cytokinetics Incorporated’s quarterly dataJuly 2025 Movers & Smart Swing Trading Techniques - newser.com
CYTOKINETICS CLASS ACTION: Bragar Eagel & Squire, P.C. - GlobeNewswire
Key facts: Cytokinetics shares plunge; class action lawsuit filed - TradingView
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics - Eastern Progress
Nisa Investment Advisors LLC Decreases Holdings in Cytokinetics, Incorporated $CYTK - Defense World
The Gross Law Firm Notifies Cytokinetics, Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineCYTK - Morningstar
35,600 Shares in Cytokinetics, Incorporated $CYTK Purchased by Zweig DiMenna Associates LLC - MarketBeat
November 17, 2025 Deadline: Join Class Action Lawsuit Against Cytokinetics, Incorporated (CYTK)Contact Levi & Korsinsky - ACCESS Newswire
Can Cytokinetics Incorporated (KK3A) stock test all time highsJuly 2025 Catalysts & Entry and Exit Point Strategies - newser.com
Cytokinetics Faces Legal and Regulatory Crossroads - AD HOC NEWS
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
How Cytokinetics Incorporated stock benefits from strong dollarJuly 2025 Gainers & Weekly Breakout Opportunity Watchlist - newser.com
Should I buy Cytokinetics Incorporated (KK3A) stock before earnings season2025 Price Momentum & High Return Stock Watch Alerts - newser.com
Does Cytokinetics Incorporated qualify in momentum factor screening2025 Market Sentiment & Fast Moving Stock Trade Plans - newser.com
Key facts: Cytokinetics' stock drops 12.98% after FDA delay; lawsuit filed - TradingView
CYTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cytokinetics, Incorporated Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
What MACD and RSI say about Cytokinetics Incorporated2025 Institutional Moves & Weekly High Potential Alerts - newser.com
Cytokinetics Incorporated recovery potential after sell off2025 Big Picture & Real-Time Volume Surge Alerts - newser.com
Pinnacle Associates Ltd. Reduces Stock Holdings in Cytokinetics, Incorporated $CYTK - MarketBeat
Why analysts remain bullish on Cytokinetics Incorporated stockMarket Movers & AI Enhanced Execution Alerts - newser.com
Is Cytokinetics Incorporated stock positioned for long term growthPortfolio Value Report & Expert Approved Momentum Ideas - newser.com
Key facts: Cytokinetics shares fall 12.98% amid FDA delay; lawsuit filed - TradingView
Cytokinetics, Incorporated (CYTK) Stock Forecasts - Yahoo Finance
Cytokinetics (NASDAQ:CYTK) Reaches New 1-Year HighHere's Why - MarketBeat
Robert Blum Sells 5,000 Shares of Cytokinetics (NASDAQ:CYTK) Stock - MarketBeat
ROSEN, A LEADING AND RANKED FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, A LEADING AND RANKED FIRM, Encourages Cytokinetics, - GlobeNewswire
Cytokinetics, Inc. Hits New 52-Week High at USD 64.13 - Markets Mojo
Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - MarketScreener
Cytokinetics Announces Upcoming Late Breaking Science Presentations on Aficamten at Major Cardiovascular Conferences - Quiver Quantitative
Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical ... - nrtoday.com
Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025 - Yahoo Finance
How sentiment analysis helps forecast Cytokinetics IncorporatedMarket Performance Recap & Weekly Stock Performance Updates - newser.com
Analyzing recovery setups for Cytokinetics Incorporated investorsJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - newser.com
What dividend safety score for Cytokinetics Incorporated stock2025 Volume Leaders & Smart Allocation Stock Tips - newser.com
Why CYTK Faces New Questions on Management Credibility Amid Regulatory Scrutiny and Investor Lawsuits - Yahoo Finance
Applying Elliott Wave Theory to Cytokinetics IncorporatedJuly 2025 Catalysts & Long-Term Capital Growth Strategies - newser.com
Is Cytokinetics Incorporated stock a smart buy before Fed meetingJuly 2025 Short Interest & Fast Moving Stock Watchlists - newser.com
How to track smart money flows in Cytokinetics IncorporatedQuarterly Portfolio Report & AI Enhanced Execution Alerts - newser.com
Blum, Cytokinetics CEO, sells $314k in stock By Investing.com - Investing.com Australia
Investors SueWallSt as Cytokinetics, Incorporated Faces Securities Fraud Allegations - ACCESS Newswire
Cytokinetics stock hits 52-week high at 63.87 USD By Investing.com - Investing.com Canada
Blum, Cytokinetics CEO, sells $314k in stock - Investing.com
Cytokinetics CEO reports sale of 5,000 shares (Form 4) - Stock Titan
Cytokinetics (CYTK): Exploring Valuation After Recent Share Price Momentum and Growth Narrative - Yahoo Finance
Cytokinetics, Incorporated Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law ... - Caledonian Record
Cytokinetics, Incorporated Securities Fraud Class Action - GlobeNewswire
Deadline Alert: Cytokinetics, Incorporated (CYTK) - GlobeNewswire
Deadline Alert: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Cytokinetics stock hits 52-week high at 63.87 USD - Investing.com
Cytokinetics (CYTK) to Release Earnings on Wednesday - MarketBeat
Cytokinetics, Incorporated $CYTK Shares Bought by State of New Jersey Common Pension Fund D - MarketBeat
1.24%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):